A comprehensive analysis of genomic determinants of response to immune checkpoint inhibitor-based immunotherapy.

被引：0
|
作者：
Yang, Jing [1 ]
Liu, Qi [1 ]
Shyr, Yu [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5018
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Total number of circulating tumor DNA (ctDNA) genomic alterations and outcome after checkpoint inhibitor-based immunotherapy.
    Khagi, Yulian
    Goodman, Aaron
    Daniels, Gregory A.
    Patel, Sandip Pravin
    Bazhenova, Lyudmila
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Predictive biomarkers for checkpoint inhibitor-based immunotherapy
    Gibney, Geoffrey T.
    Weiner, Louis M.
    Atkins, Michael B.
    LANCET ONCOLOGY, 2016, 17 (12): : E542 - E551
  • [3] Sex-specific genomic determinants of response to immunotherapy.
    Scott, Susan C.
    Shao, Xiaoshan M.
    Niknafs, Noushin
    Balan, Archana
    Lanis, Mara
    White, James
    Forde, Patrick
    Marrone, Kristen
    Lam, Vincent
    Feliciano, Josephine
    Levy, Benjamin
    Brahmer, Julie
    Ettinger, David
    Velculescu, Victor
    Karchin, Rachel
    Hann, Christine
    Naidoo, Jarushka
    Anagnostou, Valsalmo
    CANCER RESEARCH, 2021, 81 (13)
  • [4] The nephrotoxicity of immune checkpoint inhibitor-based combinations
    El Rassy, Elie
    Bakouny, Ziad
    Yared, Fares
    Chelala, Dania Nehme
    El Karak, Fadi
    Ghosn, Marwan
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : 274 - 278
  • [5] Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy
    Khagi, Yulian
    Goodman, Aaron M.
    Daniels, Gregory A.
    Patel, Sandip P.
    Sacco, Assuntina G.
    Randall, James M.
    Bazhenova, Lyudmila A.
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5729 - 5736
  • [6] Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
    Ma, Zehua
    Zhang, Weiwei
    Dong, Baijun
    Xin, Zhixiang
    Ji, Yiyi
    Su, Ruopeng
    Shen, Kai
    Pan, Jiahua
    Wang, Qi
    Xue, Wei
    THERANOSTICS, 2022, 12 (11): : 4965 - 4979
  • [7] Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer
    He, Rui
    Lao, Yefang
    Yu, Wenyan
    Zhang, Xiaohui
    Jiang, Min
    Zhu, Chunrong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [8] Rational Discovery of Response Biomarkers: Candidate Prognostic Factors and Biomarkers for Checkpoint Inhibitor-Based Immunotherapy
    Hou, Qianqian
    Xu, Heng
    REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020, 1248 : 143 - 166
  • [9] Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy
    Kubo, Terufumi
    Shinkawa, Tomoyo
    Kikuchi, Yasuhiro
    Murata, Kenji
    Kanaseki, Takayuki
    Tsukahara, Tomohide
    Hirohashi, Yoshihiko
    Torigoe, Toshihiko
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Theoretic strategy for immune checkpoint inhibitor-based combination therapy
    Chamoto, Kenji
    Hung, Mien-Chie
    CANCER SCIENCE, 2022, 113 : 1247 - 1247
12345